This course provides an in-depth exploration of biomanufacturing principles and the biological drug industry. It covers advanced topics in recombinant DNA technology, cell culture systems, bioprocess optimization, and downstream processing for large-scale production of biologics, including monoclonal antibodies, peptides, gene and cell therapies, and biosimilars. The course also examines regulatory frameworks, quality control strategies, and emerging innovations in biopharmaceutical development. Emphasis is placed on translational aspects, from bench-scale research to commercial-scale production, ensuring students gain expertise in cutting-edge biotechnological approaches driving the pharmaceutical industry.